BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Fovea Pharmaceuticals 



Paris      France
Phone: n/a Fax:


SEARCH JOBS





Segment
Start Up





 Company News
Ariana Pharma Collaborates With Fovea Pharmaceuticals On Phase II Clinical Data Analysis 2/4/2010 3:16:49 PM
Sanofi-Aventis (France) (SASY.PA) to Buy Dyax Corp. (DYAX)'s (JOBS) Drug Development Partner, Fovea Pharmaceuticals 10/13/2009 6:50:52 AM
CombinatoRx, Incorporated (CRXX)-Derived Combination Drug Candidate, Prednisporin, Acquired by Sanofi-Aventis K.K. Through Proposed Acquisition of Fovea Pharmaceuticals 10/5/2009 9:58:57 AM
Fovea Pharmaceuticals to be Acquired by Sanofi-Aventis (France) (SASY.PA) for up to $541 Million 10/1/2009 6:49:43 AM
Fovea Pharmaceuticals Reports Positive Results with Prednisporin(TM) in Persistent Allergic Conjunctivitis 5/4/2009 11:19:19 AM
CombinatoRx, Incorporated (CRXX) Collaborator Fovea Pharmaceuticals Reports Encouraging Clinical Results with CombinatoRx-Derived Combination Drug Candidate 5/4/2009 9:49:21 AM
Dyax Corp. (DYAX) (JOBS) and Fovea Pharmaceuticals Sign Development and Commercialization Agreement for DX-88 in Ophthalmic Indications 2/10/2009 6:53:09 AM
Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa 1/7/2008 10:09:01 AM
Fovea Pharmaceuticals Completes EUR30M Series B Financing 12/12/2007 6:37:01 AM
Fovea Pharmaceuticals Enter Into a Research Collaboration in Ophthalmology With Genzyme Corporation (GENZ) 11/27/2007 7:16:11 AM
12